| Reg. číslo | Kód | Liek / Účinná látka | Doplnok | Držiteľ |
|---|---|---|---|---|
| EU/1/16/1147/018 | 5486D | IBRANCE 125 mg filmom obalené tablety | tbl flm 21x125 mg (blis.PVC/OPA/Al/PVC/Al + puzdro) | PFI-BE-3 |
| EU/1/16/1147/014 | 3697D | IBRANCE 125 mg filmom obalené tablety | tbl flm 21x125 mg (blis.PVC/OPA/Al/PVC/Al) | PFI-BE-3 |
| EU/1/16/1147/012 | 3695D | IBRANCE 100 mg filmom obalené tablety | tbl flm 21x100 mg (blis.PVC/OPA/Al/PVC/Al) | PFI-BE-3 |
| EU/1/16/1147/003 | 1786C | IBRANCE 100 mg tvrdé kapsuly | cps dur 21x100 mg (blis.PVC/PCTFE/PVC/Al) | PFI-BE-3 |
| EU/1/16/1147/001 | 1784C | IBRANCE 75 mg tvrdé kapsuly | cps dur 21x75 mg (blis.PVC/PCTFE/PVC/Al) | PFI-BE-3 |
| EU/1/16/1147/017 | 5485D | IBRANCE 100 mg filmom obalené tablety | tbl flm 21x100 mg (blis.PVC/OPA/Al/PVC/Al + puzdro) | PFI-BE-3 |
| EU/1/16/1147/015 | 3698D | IBRANCE 125 mg filmom obalené tablety | tbl flm 63x125 mg (blis.PVC/OPA/Al/PVC/Al) | PFI-BE-3 |
| EU/1/16/1147/011 | 3694D | IBRANCE 75 mg filmom obalené tablety | tbl flm 63x75 mg (blis.PVC/OPA/Al/PVC/Al) | PFI-BE-3 |